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Preliminary and Short Report
THE USE OF TOPICAL THIABENDAZOLE IN
DIMETHYLSULFOXIDE FOR CREEPING
ERUPTION: PRELIMINARY
REPORT*
ROBERT KATZ, M.D. AND ROBERT W. HooD, M.D.
Although the cause of creeping eruption has
been known since 1926 (1), until recently the only
effective therapy has been nonspecific cryotherapy
which resulted in sloughing of the larva in the
blister contents. In 1964, thiabendazole, a broad
spectrum anti-helminthic, was introduced as a drug
for use in creeping eruption (2), and it has been
shown that this drug significantly modifies the
course of this disease (3). Although biopsy speci-
mens of the organism in vivo are not plentiful, it
is known that larvae burrow in the lower part of
the epidermis. It was therefore thought that
thiabendazole incorporated in dimethylsulfoxide(DMSO) might be effective when used topically
in this disease. It has been shown that DMSO
causes an increase in the percutaneous absorption
of various substances (4).
Although chronic toxicity studies in dogs have
indicated that DMSO causes refractive errors,
serious toxicity has not been reported in humans.
Furthermore, the amount of DMSO used in the
treatment of this patient and other patients with
creeping eruption to be reported in the future was
much smaller than that used in the animal studies.
CASE REPORT
A 40 year old white woman who had been
kneeling while gardening ten days prior to referral
noted the simultaneous onset of intensely pruritic
papules on both knees and upper legs three days
after her horticultural experience. At the time of
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initial examination, the patient had approximately
18 papules and 3 tracts around the right knee and
approximately 15 papules and 2 tracts around the
left knee (Fig. 1). She was treated in a double-
blind fashion with thiabendazole, 2 per cent, in
DMSO, 90 per cent, to the left knee, and DM50,
90 per cent, to the right knee. The medication,
coded, was supplied in plastic dropper bottles to
the patient and the two solutions appeared identi-
cal in every respect. The patient was instructed
to apply 15 drops of each solution to the involved
areas twice daily. After five days the left knee was
asymptomatic and the lesions were resolving, but
the lesions on the right knee had gotten worse
(Fig. 2). Nine days after therapy was started the
left knee was clear and the right knee was un-
changed (Fig. 3). The code was broken and thia-
bendazole in DMSO was then applied to the right
knee, and two weeks later all the lesions were gone
(Fig. 4). The patient noted local dryness and
slight burning for one-half hour after each applica-
tion of both solutions.
SUMMARY
A patient with creeping eruption involving both
knees was treated in a double-blind manner with
thiabendazole in dimethylsulfoxide. It is suggested
that thiabendazole in dimethylsulfoxide is the first
effective specific topical therapy for creeping erup-
tion.
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FIG. I. Bilateral papules and a few tracts before treatment.
Fie. 2. Five days after topical therapy.
FIG. 3. Nine days after initiation of therapy. Patient was now instructed to apply same
medication on right knee as she had been applying to the left knee.
FIG. 4. Thirteen days later.
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